If you enjoy this content, please share it with a colleague
Related Content
Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...
Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...
Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...
Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...
Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...
Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...
Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...
Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...
February 17, 2026 